Ming-Hui Zhao Selected Research

Propylthiouracil

3/2016	The Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in China.
6/2012	Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
2/2009	Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.
5/2007	Clinical and pathological features of renal involvement in propylthiouracil-associated ANCA-positive vasculitis.
4/2007	Follow-up of avidity and titre of anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis.
2/2007	Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
1/2007	The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil.
4/2006	The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children.
10/2005	Anti-myeloperoxidase IgG subclass distribution and avidity in sera from patients with propylthiouracil-induced antineutrophil cytoplasmic antibodies associated vasculitis.
10/2005	Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ming-Hui Zhao Research Topics

Disease

65	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2022 - 10/2005
53	Vasculitis (Vasculitides) 01/2022 - 05/2004
40	Glomerulonephritis 05/2022 - 07/2005
35	Proteinuria 07/2022 - 02/2007
29	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 12/2022 - 07/2005
24	Membranous Glomerulonephritis (Membranous Nephropathy) 12/2022 - 06/2010
24	Lupus Nephritis 01/2022 - 01/2005
17	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 09/2004
14	Microscopic Polyangiitis 09/2020 - 04/2006
13	Chronic Renal Insufficiency 01/2022 - 10/2016
13	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 06/2009
10	Infections 01/2022 - 01/2014
10	Kidney Diseases (Kidney Disease) 12/2021 - 02/2018
10	Inflammation (Inflammations) 10/2021 - 07/2005
9	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 10/2005
9	Renal Insufficiency (Renal Failure) 01/2021 - 06/2009
8	Hypertension (High Blood Pressure) 02/2022 - 12/2007
8	Neoplasms (Cancer) 01/2022 - 12/2015
8	Fibrosis (Cirrhosis) 01/2021 - 01/2007
8	Hemorrhage 01/2021 - 06/2009
8	Systemic Vasculitis 09/2020 - 04/2006
8	Nephritis 09/2020 - 01/2005
8	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2020 - 04/2006
8	IGA Glomerulonephritis (IGA Nephropathy) 01/2016 - 01/2005
7	Wounds and Injuries (Trauma) 07/2022 - 04/2016
7	Amyloidosis 01/2022 - 01/2011
6	Diabetic Nephropathies (Diabetic Nephropathy) 10/2021 - 01/2020
6	Hematuria 01/2020 - 01/2005
5	Acute Kidney Injury (Acute Renal Failure) 08/2021 - 09/2004
5	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 01/2020 - 01/2008
5	Thrombotic Microangiopathies 11/2017 - 01/2010
4	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 03/2021 - 01/2008
4	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 02/2007
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
4	Atrophy 01/2020 - 01/2007
4	Paraproteinemias (Monoclonal Gammopathy) 12/2019 - 10/2018
4	Disease Progression 01/2018 - 01/2016
3	Amyloid Plaque 01/2022 - 12/2019
3	Albuminuria 10/2021 - 09/2018
3	Multiple Myeloma 08/2021 - 11/2018
3	Diabetes Mellitus 08/2021 - 02/2018
3	Purpura 06/2020 - 01/2010
3	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 01/2017
3	Interstitial Nephritis (Tubulointerstitial Nephritis) 11/2019 - 01/2011
3	Necrosis 02/2014 - 01/2010

Drug/Important Bio-Agent (IBA)

84	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 05/2004
50	AntibodiesIBA 12/2022 - 01/2005
46	CreatinineIBA 07/2022 - 09/2004
40	AutoantibodiesIBA 12/2022 - 01/2005
26	Complement System Proteins (Complement)IBA 07/2022 - 01/2005
26	Immunoglobulin G (IgG)IBA 07/2022 - 10/2005
24	Peroxidase (Myeloperoxidase)IBA 09/2020 - 10/2005
18	antiglomerular basement membrane antibodyIBA 01/2021 - 07/2005
16	EpitopesIBA 01/2021 - 06/2009
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
14	AntigensIBA 12/2022 - 05/2004
12	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 01/2005
12	Peptides (Polypeptides)IBA 01/2021 - 06/2015
10	Complement Factor H (Factor H)IBA 01/2021 - 05/2015
10	Biomarkers (Surrogate Marker)IBA 12/2020 - 05/2007
10	Propylthiouracil FDA Link 03/2016 - 10/2005
8	Hemoglobins (Hemoglobin)IBA 08/2021 - 12/2009
8	Antigen-Antibody Complex (Immune Complex)IBA 07/2019 - 01/2006
7	Rituximab (Mabthera)FDA Link 12/2022 - 01/2018
7	Phospholipase A2 ReceptorsIBA 12/2022 - 05/2017
7	C-Reactive ProteinIBA 08/2021 - 01/2011
7	HMGB1 Protein (HMG1)IBA 01/2020 - 01/2015
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 09/2011
6	AutoantigensIBA 01/2021 - 01/2011
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2020 - 11/2009
6	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 09/2011
6	AlbuminsIBA 01/2019 - 05/2016
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2009
5	Serum AlbuminIBA 08/2021 - 05/2017
5	EnzymesIBA 11/2020 - 08/2010
5	Immunoglobulin M (IgM)IBA 01/2020 - 01/2006
5	Amino Acids FDA Link 10/2019 - 05/2011
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2006
4	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022 - 05/2015
4	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2020 - 01/2014
4	Immunoglobulin A (IgA)IBA 10/2018 - 07/2005
3	Complement C3a (Complement 3a)IBA 07/2022 - 01/2017
3	Annexin A1IBA 01/2022 - 01/2021
3	Streptozocin (Streptozotocin)FDA Link 10/2021 - 02/2018
3	HDL LipoproteinsIBA 08/2021 - 05/2017
3	Glucose (Dextrose)FDA LinkGeneric 08/2021 - 02/2018
3	MercuryIBA 03/2021 - 01/2019
3	CollagenIBA 01/2021 - 12/2016
3	ImmunosorbentsIBA 11/2020 - 07/2014
3	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 11/2019 - 01/2014
3	CholesterolIBA 01/2019 - 08/2015
3	Messenger RNA (mRNA)IBA 02/2018 - 01/2017
3	HLA Antigens (Human Leukocyte Antigens)IBA 07/2015 - 05/2011
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2006 - 05/2005

Therapy/Procedure

20	Therapeutics 12/2022 - 08/2010
5	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 11/2018
3	Lasers (Laser) 01/2022 - 01/2011
3	Transplantation 12/2020 - 01/2020
3	Plasmapheresis 01/2020 - 09/2011
3	Plasma Exchange 05/2019 - 08/2010